Latest Insider Transactions at Corbus Pharmaceuticals Holdings, Inc. (CRBP)
This section provides a real-time view of insider transactions for Corbus Pharmaceuticals Holdings, Inc. (CRBP). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Corbus Pharmaceuticals Holdings, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Corbus Pharmaceuticals Holdings, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 20
2024
|
Cormorant Asset Management, LP |
BUY
Open market or private purchase
|
Indirect |
350,000
+2.52%
|
$6,650,000
$19.93 P/Share
|
|
Aug 16
2024
|
Winston Kung |
BUY
Grant, award, or other acquisition
|
Direct |
5,566
+50.0%
|
-
|
|
Jun 18
2024
|
Yuval Cohen Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
22,938
-6.35%
|
$963,396
$42.24 P/Share
|
|
Jun 18
2024
|
Yuval Cohen Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
15,759
+5.15%
|
$252,144
$16.12 P/Share
|
|
Jun 18
2024
|
Sean F. Moran Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
1,958
-3.87%
|
$82,236
$42.12 P/Share
|
|
Jun 18
2024
|
Sean F. Moran Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,958
+3.73%
|
$58,740
$30.0 P/Share
|
|
Jun 17
2024
|
Yuval Cohen Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
11,103
-6.01%
|
$510,738
$46.02 P/Share
|
|
Jun 17
2024
|
Yuval Cohen Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
11,103
+5.53%
|
$188,751
$17.13 P/Share
|
|
Jun 17
2024
|
Sean F. Moran Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
6,730
-12.16%
|
$309,580
$46.77 P/Share
|
|
Jun 17
2024
|
Sean F. Moran Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,730
+10.84%
|
$94,220
$14.1 P/Share
|
|
Jun 14
2024
|
Yuval Cohen Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
29,317
-14.76%
|
$1,465,850
$50.17 P/Share
|
|
Jun 14
2024
|
Yuval Cohen Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
29,317
+12.84%
|
$263,853
$9.18 P/Share
|
|
Jun 14
2024
|
Sean F. Moran Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
9,355
-8.47%
|
$458,395
$49.87 P/Share
|
|
Jun 14
2024
|
Sean F. Moran Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
9,355
+7.58%
|
$159,035
$17.13 P/Share
|
|
Jun 14
2024
|
Alan F Holmer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,667
+22.24%
|
$50,010
$30.0 P/Share
|
|
May 30
2024
|
Peter Salzmann |
BUY
Grant, award, or other acquisition
|
Direct |
2,783
+50.0%
|
-
|
|
May 30
2024
|
Avery W Catlin |
BUY
Grant, award, or other acquisition
|
Direct |
2,783
+39.02%
|
-
|
|
May 30
2024
|
John Kenneth Jenkins |
BUY
Grant, award, or other acquisition
|
Direct |
2,783
+49.71%
|
-
|
|
May 30
2024
|
Anne Altmeyer |
BUY
Grant, award, or other acquisition
|
Direct |
2,783
+50.0%
|
-
|
|
May 30
2024
|
Alan F Holmer |
BUY
Grant, award, or other acquisition
|
Direct |
2,783
+40.07%
|
-
|
|
May 30
2024
|
Ben Yong |
BUY
Grant, award, or other acquisition
|
Direct |
2,783
+50.0%
|
-
|
|
May 30
2024
|
Rachelle Suzanne Jacques |
BUY
Grant, award, or other acquisition
|
Direct |
2,783
+50.0%
|
-
|
|
Apr 10
2024
|
Sean F. Moran Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,787
+3.55%
|
$53,610
$30.0 P/Share
|
|
Mar 08
2024
|
Cormorant Asset Management, LP |
BUY
Open market or private purchase
|
Indirect |
300,000
+2.48%
|
$12,900,000
$43.76 P/Share
|
|
Mar 07
2024
|
Cormorant Asset Management, LP |
BUY
Open market or private purchase
|
Indirect |
250,000
+3.64%
|
$9,750,000
$39.54 P/Share
|
|
Feb 27
2024
|
Dominic Smethurst Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
50,000
+50.0%
|
-
|
|
Feb 12
2024
|
Sean F. Moran Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
40,176
+46.18%
|
-
|
|
Feb 12
2024
|
Yuval Cohen Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
73,947
+46.7%
|
-
|
|
Feb 02
2024
|
Cormorant Asset Management, LP |
BUY
Open market or private purchase
|
Indirect |
750,000
+33.71%
|
$14,250,000
$19.0 P/Share
|
|
Jan 26
2024
|
Alan F Holmer |
BUY
Exercise of conversion of derivative security
|
Direct |
629
+31.32%
|
$2,516
$4.97 P/Share
|
|
Jan 26
2024
|
Yuval Cohen Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,179
+50.0%
|
$28,716
$4.97 P/Share
|
|
Jan 26
2024
|
Cormorant Asset Management, LP |
BUY
Open market or private purchase
|
Indirect |
282,632
+3.28%
|
$9,044,224
$32.17 P/Share
|
|
Aug 10
2022
|
Craig Stuart Millian Chief Operating Officer |
BUY
Open market or private purchase
|
Direct |
5,000
+15.63%
|
$0
$0.25 P/Share
|
|
Aug 10
2022
|
Yuval Cohen Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
3,800
+3.72%
|
$0
$0.26 P/Share
|
|
Aug 10
2022
|
Sean F. Moran Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
20,000
+9.12%
|
$0
$0.26 P/Share
|
|
May 16
2022
|
Yuval Cohen Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
10,500
+10.01%
|
$0
$0.25 P/Share
|
|
May 16
2022
|
Sean F. Moran Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
12,000
+6.27%
|
$0
$0.3 P/Share
|
|
Mar 10
2022
|
Craig Stuart Millian Chief Operating Officer |
BUY
Open market or private purchase
|
Direct |
10,000
+31.25%
|
$0
$0.37 P/Share
|
|
Mar 10
2022
|
Sean F. Moran Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
15,000
+8.23%
|
$0
$0.37 P/Share
|
|
Mar 09
2022
|
Yuval Cohen Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
8,600
+9.29%
|
$0
$0.37 P/Share
|
|
Dec 21
2020
|
Sean F. Moran Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
87,500
-20.02%
|
$87,500
$1.75 P/Share
|
|
Dec 21
2020
|
Sean F. Moran Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
87,500
+16.68%
|
$87,500
$1.4 P/Share
|
|
Dec 18
2020
|
Sean F. Moran Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
53,610
-13.3%
|
$53,610
$1.4 P/Share
|
|
Dec 18
2020
|
Sean F. Moran Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
53,610
+11.74%
|
$53,610
$1.0 P/Share
|
|
Dec 16
2020
|
Sean F. Moran Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
36,923
-9.55%
|
$36,923
$1.32 P/Share
|
|
Dec 16
2020
|
Sean F. Moran Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
36,923
+8.72%
|
$0
$0.17 P/Share
|
|
Nov 11
2020
|
Yuval Cohen Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
4,240
+5.33%
|
$4,240
$1.21 P/Share
|